Glunz & Jensen Holding A/S
10.4.2026 18:29:23 CEST | Globenewswire | Press release
Purchase of shares
Purchase of shares
To Nasdaq OMX Copenhagen A/S
Public announcement no. 589
April 10th, 2026
MANAGER’S TRANSACTION
Glunz & Jensen Holding A/S announces that the company today has received pursuant to section 38 of the Capital Market Act and section 55 of the Danish Companies Act, where Flemming Nyenstad Enevoldsen notifies Glunz & Jensen Holding A/S ("Glunz & Jensen") that Flemming Nyenstad Enevoldsen has increased his shareholding in Glunz & Jensen by purchasing 616 shares in Glunz & Jensen at nominal DKK 20.
After the purchase, Flemming Nyenstad Enevoldsen owns a total of 12.651 shares, corresponding to 0,69 % of the total share capital and voting rights in Glunz & Jensen.
Flemming Nyenstad Enevoldsen is a member of the board of directors of Glunz & Jensen Holding A/S since 2017, and Flemming Nyenstad Enevoldsen is the Chairman of the board of Directors in Glunz & Jensen Holding A/S since 2019.
See attached information for further details.
For further information please contact:
CEO Henrik Blegvad Funk: phone +45 21 39 05 32
Chairman of the board Flemming Nyenstad Enevoldsen: phone +45 40 43 13 03
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Vislink LTD17.8.2026 14:42:27 CEST | Press release
Vislink to Present at the Emerging Growth Conference on Wednesday, August 19, 2026
The Metals Company17.8.2026 14:30:00 CEST | Press release
NOAA Publishes Notice of Intent in the Federal Register to Prepare an Environmental Impact Statement for TMC USA’s USA-B Exploration License Application
Novo Nordisk A/S17.8.2026 14:21:04 CEST | Press release
Novo Nordisk A/S - share repurchase programme
Intuitive Machines, LLC17.8.2026 14:00:00 CEST | Press release
Intuitive Machines Selected for Multi-Satellite Communications Infrastructure Program
Evaxion17.8.2026 14:00:00 CEST | Press release
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom